Genmab is expanding its UK market access capabilities, shaping HTA submissions and reimbursement strategies for oncology assets. The role offers substantial ownership, direct interaction with UK decision-makers and a chance to influence evidence plans across regional and global teams.
The Associate Director will lead end-to-end HTA submissions, coordinate clinical and economic evidence, and collaborate with Head of Market Access and Pricing to define pricing and access scenarios for UK
#J-18808-Ljbffr
UK Market Access Lead β Oncology HTA & Reimbursement in London employer: Genmab
At Genmab, we pride ourselves on being an exceptional employer that fosters a culture of innovation, collaboration, and compassion. Our agile working environment in the UK not only enhances work-life balance but also encourages personal and professional growth through meaningful contributions to groundbreaking cancer treatments. Join us to be part of a passionate team that values authenticity and strives to make a significant impact while having fun along the way.